Citigroup Inc Keros Therapeutics, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 2,917 shares of KROS stock, worth $50,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,917

Previous 34,379 91.52%

Holding current value

$50,347

Previous $458,000 89.96%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$13.34 - $16.05 $419,703 - $504,965	-31,462 Reduced 91.52%	2,917 $46,000
Q2 2025 Aug 11, 2025	SELL	$9.55 - $15.11 $356,959 - $564,781	-37,378 Reduced 52.09%	34,379 $458,000
Q1 2025 May 12, 2025	BUY	$10.15 - $16.1 $175,940 - $279,077	17,334 Added 31.85%	71,757 $731,000
Q4 2024 Feb 12, 2025	BUY	$15.64 - $70.0 $485,496 - $2.17 Million	31,042 Added 132.77%	54,423 $861,000
Q3 2024 Nov 12, 2024	BUY	$41.68 - $58.07 $450,060 - $627,039	10,798 Added 85.81%	23,381 $1.36 Million

Q2 2024 Aug 12, 2024	SELL	$44.58 - $66.89 $4.68 Million - $7.01 Million	-104,873 Reduced 89.29%	12,583 $575,000
Q1 2024 May 10, 2024	SELL	$41.26 - $70.48 $2.14 Million - $3.66 Million	-51,935 Reduced 30.66%	117,456 $7.78 Million
Q4 2023 Feb 09, 2024	BUY	$27.12 - $41.05 $1.93 Million - $2.93 Million	71,282 Added 72.66%	169,391 $6.73 Million
Q3 2023 Nov 09, 2023	SELL	$31.57 - $43.02 $1.73 Million - $2.35 Million	-54,738 Reduced 35.81%	98,109 $3.13 Million
Q2 2023 Aug 10, 2023	SELL	$37.26 - $51.01 $6.45 Million - $8.84 Million	-173,217 Reduced 53.12%	152,847 $6.14 Million
Q1 2023 May 11, 2023	SELL	$41.44 - $59.32 $3.57 Million - $5.1 Million	-86,039 Reduced 20.88%	326,064 $13.9 Million
Q4 2022 Feb 09, 2023	SELL	$39.45 - $51.77 $2.53 Million - $3.31 Million	-64,020 Reduced 13.45%	412,103 $19.8 Million
Q3 2022 Nov 10, 2022	BUY	$27.8 - $40.12 $382,333 - $551,770	13,753 Added 2.97%	476,123 $17.9 Million
Q2 2022 Aug 10, 2022	BUY	$26.03 - $67.04 $11.8 Million - $30.5 Million	454,498 Added 5773.6%	462,370 $12.8 Million
Q1 2022 May 12, 2022	SELL	$42.12 - $59.36 $1.02 Million - $1.44 Million	-24,248 Reduced 75.49%	7,872 $428,000
Q4 2021 Feb 10, 2022	BUY	$36.95 - $62.89 $499,490 - $850,147	13,518 Added 72.67%	32,120 $1.88 Million
Q3 2021 Nov 10, 2021	BUY	$29.27 - $43.71 $544,480 - $813,093	18,602 New	18,602 $736,000

Others Institutions Holding KROS

# of Institutions

169

Shares Held

35.4M

Call Options Held

574K

Put Options Held

325K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account